SLC5A2 and metabolic dysfunction-associated steatotic liver disease: NAFLD: non-alcoholic fatty liver disease; OSA: obstructive sleep apnea; UTI: urinary tract infection; SGLT2I: sodium-glucose cotransporter-2 inhibitor